Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study.
Yamada T, Shimonagata T, Fukunami M, Kumagai K, Ogita H, Hirata A, Asai M, Makino N, Kioka H, Kusuoka H, Hori M, Hoki N. Yamada T, et al. J Am Coll Cardiol. 2003 Jan 15;41(2):231-8. doi: 10.1016/s0735-1097(02)02700-6. J Am Coll Cardiol. 2003. PMID: 12535815 Free article. Clinical Trial.
Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.
Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, Masuda M, Okuda K, Iwasaki Y, Yasui T, Hori M, Fukunami M. Tamaki S, et al. Among authors: yamada t. J Am Coll Cardiol. 2009 Feb 3;53(5):426-35. doi: 10.1016/j.jacc.2008.10.025. J Am Coll Cardiol. 2009. PMID: 19179201 Free article.
Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure.
Kuramoto Y, Yamada T, Tamaki S, Okuyama Y, Morita T, Furukawa Y, Tanaka K, Iwasaki Y, Yasui T, Ueda H, Okada T, Kawasaki M, Levy WC, Komuro I, Fukunami M. Kuramoto Y, et al. Among authors: yamada t. Am J Cardiol. 2011 Apr 15;107(8):1185-90. doi: 10.1016/j.amjcard.2010.12.019. Epub 2011 Feb 23. Am J Cardiol. 2011. PMID: 21349482
Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for sudden cardiac death.
Kawai T, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kondo T, Takahashi S, Ishimi M, Hakui H, Ozaki T, Sato Y, Seo M, Sakata Y, Fukunami M. Kawai T, et al. Among authors: yamada t. Am J Cardiol. 2015 Jun 1;115(11):1549-54. doi: 10.1016/j.amjcard.2015.02.058. Epub 2015 Mar 12. Am J Cardiol. 2015. PMID: 25851796
Usefulness of Cardiac MetaIodobenzylguanidine Imaging to Improve Prognostic Power of the Model for End-Stage Liver Disease Scoring System in Patients With Mild-to-Moderate Chronic Heart Failure.
Hakui H, Yamada T, Tamaki S, Morita T, Furukawa Y, Iwasaki Y, Kawasaki M, Kikuchi A, Kondo T, Ishimi M, Sato Y, Seo M, Ozaki T, Ikeda I, Fukuhara E, Sakata Y, Fukunami M. Hakui H, et al. Among authors: yamada t. Am J Cardiol. 2016 Jun 15;117(12):1947-52. doi: 10.1016/j.amjcard.2016.03.047. Epub 2016 Apr 6. Am J Cardiol. 2016. PMID: 27237625
Prognostic value of cardiac metaiodobenzylguanidine imaging and QRS duration in implantable cardioverter defibrillator patients with and without heart failure.
Kawasaki M, Yamada T, Morita T, Furukawa Y, Tamaki S, Iwasaki Y, Kikuchi A, Kawai T, Seo M, Hirota Kida, Sakata Y, Fukunami M. Kawasaki M, et al. Among authors: yamada t. Int J Cardiol. 2019 Dec 1;296:164-171. doi: 10.1016/j.ijcard.2019.07.068. Epub 2019 Jul 23. Int J Cardiol. 2019. PMID: 31371118
12,227 results
You have reached the last available page of results. Please see the User Guide for more information.